![US budget impact analysis of esketamine nasal spray in major depressive disorder with acute suicidal ideation/behavior US budget impact analysis of esketamine nasal spray in major depressive disorder with acute suicidal ideation/behavior](https://becarispublishing.com/cms/10.2217/cer-2021-0226/asset/839401f3-9d0b-41d6-817b-fcd2dc337194/assets/images/large/figure2.jpg)
US budget impact analysis of esketamine nasal spray in major depressive disorder with acute suicidal ideation/behavior
![Esketamine Spravato 28mg/84mg Nasal Spray EU UK USA Delivery at Rs 6000/box | Pharmaceutical Tablets in Bardhaman | ID: 2852839895155 Esketamine Spravato 28mg/84mg Nasal Spray EU UK USA Delivery at Rs 6000/box | Pharmaceutical Tablets in Bardhaman | ID: 2852839895155](http://5.imimg.com/data5/SELLER/Default/2023/11/359615528/OC/TW/NI/193851871/img-20231107-wa0016-500x500.jpg)
Esketamine Spravato 28mg/84mg Nasal Spray EU UK USA Delivery at Rs 6000/box | Pharmaceutical Tablets in Bardhaman | ID: 2852839895155
![SPRAVATO ®▽ (esketamine) nasal spray approved for reimbursement in Ireland for adults with treatment-resistant major depressive disorder - Hospital Professional News SPRAVATO ®▽ (esketamine) nasal spray approved for reimbursement in Ireland for adults with treatment-resistant major depressive disorder - Hospital Professional News](https://hospitalprofessionalnews.ie/wp-content/uploads/2022/03/spravato-esketamine-spray-233x300-1.png)
SPRAVATO ®▽ (esketamine) nasal spray approved for reimbursement in Ireland for adults with treatment-resistant major depressive disorder - Hospital Professional News
![SPRAVATO®▽ (Esketamine) Nasal Spray Approved in Europe for Adults with Treatment-Resistant Major Depressive Disorder | Business Wire SPRAVATO®▽ (Esketamine) Nasal Spray Approved in Europe for Adults with Treatment-Resistant Major Depressive Disorder | Business Wire](https://mms.businesswire.com/media/20191219005272/en/764047/4/WebReady480.jpg)
SPRAVATO®▽ (Esketamine) Nasal Spray Approved in Europe for Adults with Treatment-Resistant Major Depressive Disorder | Business Wire
![Cost-Effectiveness of Esketamine Nasal Spray for Patients With Treatment-Resistant Depression in the United States | Psychiatric Services Cost-Effectiveness of Esketamine Nasal Spray for Patients With Treatment-Resistant Depression in the United States | Psychiatric Services](https://ps.psychiatryonline.org/cms/10.1176/appi.ps.201900625/asset/images/medium/appi.ps.201900625f1.gif)
Cost-Effectiveness of Esketamine Nasal Spray for Patients With Treatment-Resistant Depression in the United States | Psychiatric Services
![Esketamine Spravato 28mg/84mg Nasal Spray Finland USA Delivery, Strength: 56 mg at Rs 6099/box in Bardhaman Esketamine Spravato 28mg/84mg Nasal Spray Finland USA Delivery, Strength: 56 mg at Rs 6099/box in Bardhaman](http://5.imimg.com/data5/SELLER/Default/2023/11/359615474/OP/KX/DW/193851871/img-20231107-wa0012-500x500.jpg)
Esketamine Spravato 28mg/84mg Nasal Spray Finland USA Delivery, Strength: 56 mg at Rs 6099/box in Bardhaman
![SPRAVATO®▽ approved for reimbursement in Ireland for adults with treatment-resistant major depressive disorder SPRAVATO®▽ approved for reimbursement in Ireland for adults with treatment-resistant major depressive disorder](https://d1l0gza1nowsqe.cloudfront.net/wp-content/uploads/sites/4/2022/05/Spravato6001PPS0_620.jpg)
SPRAVATO®▽ approved for reimbursement in Ireland for adults with treatment-resistant major depressive disorder
![NHS rejects ketamine for depression as psychiatrists accuse NICE of mental health discrimination | Daily Mail Online NHS rejects ketamine for depression as psychiatrists accuse NICE of mental health discrimination | Daily Mail Online](https://i.dailymail.co.uk/1s/2022/09/17/15/62509625-11222317-image-a-18_1663425907764.jpg)
NHS rejects ketamine for depression as psychiatrists accuse NICE of mental health discrimination | Daily Mail Online
![Cost-effectiveness of esketamine nasal spray compared to intravenous ketamine for patients with treatment-resistant depression in the US utilizing clinical trial efficacy and real-world effectiveness estimates Cost-effectiveness of esketamine nasal spray compared to intravenous ketamine for patients with treatment-resistant depression in the US utilizing clinical trial efficacy and real-world effectiveness estimates](https://blossomanalysis.com/wp-content/uploads/2021/12/Research-Papers-Psychedelics-B.jpg)